Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Metoclopramide Tablets Recalled for Potential Foreign Tablets or Capsules

Agency Publication Date: June 20, 2025
Share:
Sign in to monitor this recall

Summary

Teva Pharmaceuticals USA, Inc. is recalling approximately 36,612 cartons of Metoclopramide Tablets (10 mg), a prescription medication used to treat digestive and gastric issues. The recall was initiated because some 100-count bottles may contain foreign tablets or capsules that are not the intended medication. This product was manufactured in Croatia for Teva and sold across the United States.

Risk

Taking a foreign tablet or capsule instead of the prescribed medication may cause serious adverse health effects, allergic reactions, or drug interactions depending on the nature of the unknown substance. Additionally, patients will miss their intended dose of Metoclopramide, which could lead to a worsening of their medical condition.

What You Should Do

  1. The recalled product is Metoclopramide Tablets, USP 10 mg, sold in 100-count bottles (NDC 0093-2203-01) with lot number 5420094 and an expiration date of 09/30/2027.
  2. If you have health concerns, contact your healthcare provider or pharmacist.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact Teva Pharmaceuticals USA, Inc for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Metoclopramide Tablets, USP 10 mg (100-count bottle)by Teva
Variants: 10 mg, Tablet
Lot Numbers:
5420094 (Exp 09/30/2027)
NDC:
0093-2203-01

Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, for Teva Pharmaceuticals. Recall number D-0473-2025.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96919
Status: Active
Manufacturer: Teva Pharmaceuticals USA, Inc
Sold By: Pharmacies
Manufactured In: Croatia
Units Affected: 36612 cartons
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.